MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202518123111 A) filed by Cellectar Biosciences, Inc. on December 06, 2025, for Phospholipid-Flavagline Conjugates And Methods Of Using The Same For Targeted Cancer Therapy.
Inventor includes Longcor, Jarrod.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: Disclosed herein are phospholipid ether (PLE) molecules. Further provided are phospholipid-flavagline conjugates. The phospholipid-flavagline conjugate may include a PLE conjugated to a flavagline via a linker. Further provided herein are methods of treating cancer in a subject and methods of targeting a drug to a tumor or cancer cell in a subject...